Gradient Investments LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$37
+48.0%
630.0%0.00%
Q4 2022$25630.0%0.00%
Q3 2022$0630.0%0.00%
Q2 2022$0630.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 129,891$69,0000.01%
Hudson Bay Capital Management LP 230,000$123,0000.00%
Renaissance Technologies 1,879,137$1,004,0000.00%
ROYAL BANK OF CANADA 89$00.00%
Gradient Investments LLC 63$00.00%
VANGUARD GROUP INC 858,416$459,0000.00%
OPTIMUM INVESTMENT ADVISORS 16$00.00%
Focused Wealth Management, Inc 222$00.00%
FEDERATED HERMES, INC. 907$1,0000.00%
JANE STREET GROUP, LLC 24,985$13,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders